jab 相關
廣告
搜尋結果
FDA approves GSK's RSV vaccine for high-risk adults ages 50 to 59, expanding shot's reach
CNBC· 7 小時前The Food and Drug Administration on Friday expanded the approval of GSK's respiratory ...
jab 相關
廣告
The Food and Drug Administration on Friday expanded the approval of GSK's respiratory ...